Health Care & Life Sciences » Pharmaceuticals | Kindred Biosciences Inc.

Kindred Biosciences Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
65,328.80
101,027.00
73,043.00
56,755.00
81,020.00
73,932
Other Current Assets
147.60
477.00
712.00
1,282.00
797.00
1,664
Total Current Assets
65,476.40
101,504.00
73,755.00
58,037.00
81,817.00
80,069
Net Property, Plant & Equipment
11.70
394.00
1,244.00
2,441.00
7,457.00
26,343
Total Investments and Advances
-
-
4,590.00
1,052.00
1,499.00
-
Other Assets
-
22.00
30.00
46.00
49.00
70
Total Assets
65,488.10
101,920.00
79,619.00
61,576.00
90,822.00
106,482
Accounts Payable
688.60
-
-
410.00
1,439.00
Other Current Liabilities
1,521.00
2,896.00
3,208.00
3,457.00
4,588.00
Total Current Liabilities
2,209.60
2,896.00
3,208.00
3,867.00
6,027.00
Other Liabilities
-
-
40.00
29.00
115.00
Total Liabilities
2,209.60
2,896.00
3,248.00
3,896.00
6,142.00
Common Equity (Total)
63,278.50
99,024.00
76,371.00
57,680.00
84,680.00
Total Shareholders' Equity
63,278.50
99,024.00
76,371.00
57,680.00
84,680.00
Total Equity
63,278.50
99,024.00
76,371.00
57,680.00
84,680.00
Liabilities & Shareholders' Equity
65,488.10
101,920.00
79,619.00
61,576.00
90,822.00

About Kindred Biosciences

View Profile
Address
1555 Bayshore Highway
Burlingame California 94010
United States
Employees -
Website http://www.kindredbio.com
Updated 07/08/2019
Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.